APA (7th ed.) Citation

S, M., N, G., EV, C., F, O., I, H., N, Y., . . . SS, A. K. (2022). Safety and Pharmacokinetics of Monoclonal Antibodies VRC07-523LS and PGT121 Administered Subcutaneously for Human Immunodeficiency Virus Prevention. The Journal of infectious diseases, 226(3), 510. https://doi.org/10.1093/infdis/jiac041

Chicago Style (17th ed.) Citation

S, Mahomed, et al. "Safety and Pharmacokinetics of Monoclonal Antibodies VRC07-523LS and PGT121 Administered Subcutaneously for Human Immunodeficiency Virus Prevention." The Journal of Infectious Diseases 226, no. 3 (2022): 510. https://doi.org/10.1093/infdis/jiac041.

MLA (9th ed.) Citation

S, Mahomed, et al. "Safety and Pharmacokinetics of Monoclonal Antibodies VRC07-523LS and PGT121 Administered Subcutaneously for Human Immunodeficiency Virus Prevention." The Journal of Infectious Diseases, vol. 226, no. 3, 2022, p. 510, https://doi.org/10.1093/infdis/jiac041.